课题基金 / 基金详情

Analysis of leukemia stem cell regulation by leukemia oncogene Evi-1

Analysis of leukemia stem cell regulation by leukemia oncogene Evi-1
白血病癌基因Evi-1对白血病干细胞的调控分析
批准号:
21890055
负责人:
SATO Tomohiko
金额:
$1.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Research Activity Start-up
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2010
关键词:

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have recently generated Evi-1-GFP knock-in mice, which can trace Evi1 mRNA level in vivo, and we revealed that Evi-1 is highly expressed at both fetal and adult hematopoietic stem cells (HSCs). In addition, we also clarified that Evi-1 positive murine HSC (KSL) function as long-term HSC by bone marrow transplantation assay, and that Evi-1 can mark long-term HSC which is the most immature hematopoietic cells. (These data are now on submission) Next, for the analysis of leukemia stem cell regulation by Evi-1, we made chronic myeloid leukemia (CML) mouse of Evi-1-GFP knockin origin by using BCR-ABL oncogene. We revealed that Evi-1 positive KSL cells had highest Evi-1 expression in these model mice which implied that Evi-1 could regulate CML stem cells. Our original analysis of leukemia stem cell is still ongoing for the purpose of establishing specific therapy of CML stem cells.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Evi1 expression marks long-term repopulating hematopoietic stem cells.
Evi1 表达标志着造血干细胞的长期再生。
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [Keisuke Kataoka, Tomohiko Sato, Akihide Yoshimi, Susumu Goyama, Shunya Arai, Yoichi Imai, Katsuyoshi Kumagai, Naoto Kubota, Takashi Kadowaki, Mineo Kurokawa]
通讯作者: Mineo Kurokawa
Evi1 Is a Stem Cell-Specific Regulator of Self-Renewal Capacity In the Definitive Hematopoietic System
Evi1 是决定性造血系统中自我更新能力的干细胞特异性调节因子
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [Keisuke Kataoka, Tomohiko Sato, Akihide Yoshimi, Susumu Goyama, Takako Tsuruta, Shunya Arai, Yoichi Imai, Katsuyoshi Kumagai, Naoto Kubota, Takashi Kadowaki, Mineo Kurokawa]
通讯作者: Mineo Kurokawa
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
国内基金
海外基金
基于多组学与可视化免疫动态成像技术解析EZH2抑制对增强CAR-NK细胞抗AML效应的机制研究
  • 批准号:
    JCZRLH202600775
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
USP43-SAFB1轴调控FLT3突变急性髓系白血病细胞对FLT3抑制剂耐药的机制研究
  • 批准号:
    JCZRQNB202600664
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
DADS调控自噬流转换决定AML细胞命运的机制研究
MSI2 通过 YTHDF2 介导的m6A 修饰调控CD48/CD244 信号通路促进急性髓系白血病免疫逃逸的机制研究
  • 批准号:
    ZCLQN26H0801
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    李帆帆
  • 依托单位: